SCHEMBL11246753

SCHEMBL11246753

C1=Cc2sc3ccccc3c2SN1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.41
MAPT P10636 2/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A1 P04798 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
HTR2A P28223 1/20 0.32
CYP2C19 P33261 1/20 0.32
IDO1 P14902 1/20 0.32
ALDH1A1 P00352 3/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
CASP1 P29466 1/20 0.31
LOXL2 Q9Y4K0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL291779 0.69 GPR3 (0.40) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL278665 0.68 GPR3 (0.43) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL30875499 0.66 GPR3 (0.40) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL17675486 0.66 GPR3 (0.40) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL6545120 0.63 GPR3 (0.52) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL10671329 0.63 LIMK1 (0.43) GPR3MAPTRAB9AMEN1KMT2A
Dibenzothiophene SCHEMBL13294 0.62 GPR3 (1.00) GPR3MAPTRAB9AMEN1KMT2A
Dibenzothiophene SCHEMBL30167635 0.62 GPR3 (1.00) GPR3MAPTRAB9AMEN1KMT2A
Dibenzothiophene SCHEMBL14659543 0.62 GPR3 (1.00) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL12228803 0.60 GPR3 (0.55) GPR3MAPTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114007649-A Targeted synergistic cancer immunotherapy 布里格姆及妇女医院股份有限公司 2022-02-01 CN claimed
EP-3575791-B1 BLOOD TREATMENT METHOD AND BLOOD COLLECTION TUBE ARKRAY INC (JP) 2024-01-10 EP disclosed
CN-114007649-A Targeted synergistic cancer immunotherapy 布里格姆及妇女医院股份有限公司 2022-02-01 CN disclosed
EP-3575791-A1 BLOOD TREATMENT METHOD AND BLOOD COLLECTION TUBE ARKRAY, Inc. (JP) 2019-12-04 EP disclosed
US-4348519-A ANTIINFLAMMATORY, ANALGESIC, ANTIRHEUMATIC, ANTITHROMBOTIC HOFFMANN-LA ROCHE INC. (US) 1982-09-07 US disclosed
EP-0021058-A3 DERIVATIVES OF BENZOTHIENOTHIAZINE, THEIR USE, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-01-28 EP disclosed
EP-0021058-A2 Derivatives of benzothienothiazine, their use, process and intermediates for their preparation and pharmaceutical compositions containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-01-07 EP disclosed
EP-0021058-A2 Derivatives of benzothienothiazine, their use, process and intermediates for their preparation and pharmaceutical compositions containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-01-07 EP disclosed